Search research articles
Contact Us
Filters
Showing results (101-110 of 283) with videos related to
Page
of 29
Sort By:
The Journal of Clinical Psychiatry
|
February 7, 2014
National trends in second-generation antipsychotic augmentation for nonpsychotic depression
Tobias Gerhard, Ayse Akincigil, Christoph U Correll, et al.
Schizophrenia Bulletin
|
February 11, 2011
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia
Mark Olfson, Tobias Gerhard, Cecilia Huang, et al.
Public Health Reports (Washington, D.C. : 1974)
|
August 13, 2011
Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia
James Walkup, Ayse Akincigil, Donald R Hoover, et al.
JAMA Psychiatry
|
May 26, 2021
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span
Mark Olfson, T Scott Stroup, Cecilia Huang, et al.
JAMA Network Open
|
June 1, 2022
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
Thuy Nguyen, Engy Ziedan, Kosali Simon, et al.
Psychiatric Services (Washington, D.C.)
|
September 2, 2008
Hospitalization for psychiatric illness among community-dwelling elderly persons in 1992 and 2002
Ayse Akincigil, Donald R Hoover, James T Walkup, et al.
Medical Care
|
May 15, 2007
Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes
Quanwu Zhang, Monika Safford, Donald Miller, et al.
Health Affairs (Project Hope)
|
July 8, 2016
Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid
Kimberly E Hoagwood, Kelly Kelleher, Bonnie T Zima, et al.
JAMA Psychiatry
|
September 23, 2016
Short-term Suicide Risk After Psychiatric Hospital Discharge
Mark Olfson, Melanie Wall, Shuai Wang, et al.
JAMA Health Forum
|
June 2, 2023
Hospital Use and Mortality Among Decarcerated Individuals With Substance Use Disorder After a Large-scale COVID-19 Emergency Prison Release Program
Peter Treitler, Molly Nowels, Kenneth A Feder, et al.
Page
of 29
Search research articles
Search
Showing results (101-110 of 283) with videos related to
Sort By:
Page
of 29
The Journal of Clinical Psychiatry
|
February 7, 2014
National trends in second-generation antipsychotic augmentation for nonpsychotic depression
Tobias Gerhard, Ayse Akincigil, Christoph U Correll, et al.
Schizophrenia Bulletin
|
February 11, 2011
Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia
Mark Olfson, Tobias Gerhard, Cecilia Huang, et al.
Public Health Reports (Washington, D.C. : 1974)
|
August 13, 2011
Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia
James Walkup, Ayse Akincigil, Donald R Hoover, et al.
JAMA Psychiatry
|
May 26, 2021
Suicide Risk in Medicare Patients With Schizophrenia Across the Life Span
Mark Olfson, T Scott Stroup, Cecilia Huang, et al.
JAMA Network Open
|
June 1, 2022
Racial and Ethnic Disparities in Buprenorphine and Extended-Release Naltrexone Filled Prescriptions During the COVID-19 Pandemic
Thuy Nguyen, Engy Ziedan, Kosali Simon, et al.
Psychiatric Services (Washington, D.C.)
|
September 2, 2008
Hospitalization for psychiatric illness among community-dwelling elderly persons in 1992 and 2002
Ayse Akincigil, Donald R Hoover, James T Walkup, et al.
Medical Care
|
May 15, 2007
Short-term statin exposure is associated with reduced all-cause mortality in persons with diabetes
Quanwu Zhang, Monika Safford, Donald Miller, et al.
Health Affairs (Project Hope)
|
July 8, 2016
Ten-Year Trends In Treatment Services For Children With Attention Deficit Hyperactivity Disorder Enrolled In Medicaid
Kimberly E Hoagwood, Kelly Kelleher, Bonnie T Zima, et al.
JAMA Psychiatry
|
September 23, 2016
Short-term Suicide Risk After Psychiatric Hospital Discharge
Mark Olfson, Melanie Wall, Shuai Wang, et al.
JAMA Health Forum
|
June 2, 2023
Hospital Use and Mortality Among Decarcerated Individuals With Substance Use Disorder After a Large-scale COVID-19 Emergency Prison Release Program
Peter Treitler, Molly Nowels, Kenneth A Feder, et al.
Page
of 29